Skip to main content
Year archive

SeouLinBioscienceCO.,LTD. — 2022 filings

All 26 regulatory filings released by SeouLinBioscienceCO.,LTD. (038070) in 2022, sourced directly from the official regulator.

26 Filings
2022 Period
2022 filings (26)
Filing Released Lang
배당락(주식배당)
Notice of Dividend Amount
2022-12-27 Korean
[기재정정]주주명부폐쇄기간또는기준일설정
Notice of Dividend Amount
2022-12-14 Korean
현금ㆍ현물배당을위한주주명부폐쇄(기준일)결정
Notice of Dividend Amount
2022-12-14 Korean
주식배당결정
Notice of Dividend Amount
2022-12-14 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings
2022-12-12 Korean
분기보고서 (2022.09)
Interim / Quarterly Report 9M 2022
2022-11-14 Korean
[기재정정]사업보고서 (2021.12)
Annual Report FY 2021
2022-08-16 Korean
반기보고서 (2022.06)
Interim / Quarterly Report H1 2022
2022-08-16 Korean
전환가액의조정
Share Issue/Capital Change
2022-05-24 Korean
분기보고서 (2022.03)
Interim / Quarterly Report Q1 2022
2022-05-16 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2022-03-23 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2022-03-23 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2022-03-23 Korean
[기재정정]정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements
2022-03-22 Korean
전환가액의조정
Share Issue/Capital Change
2022-03-18 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements
2022-03-18 Korean
감사보고서제출
Audit Report / Information FY 2021
2022-03-10 Korean
[기재정정]주주총회소집공고
Proxy Solicitation & Information Statement
2022-03-10 Korean
[기재정정]의결권대리행사권유참고서류
Proxy Solicitation & Information Statement
2022-03-10 Korean
사업보고서 (2021.12)
Annual Report FY 2021
2022-03-10 Korean
주주총회소집공고
AGM Information
2022-03-03 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement
2022-03-03 Korean
전환가액의조정
Share Issue/Capital Change
2022-02-24 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release FY 2021
2022-02-17 Korean
현금ㆍ현물배당결정
Notice of Dividend Amount
2022-02-17 Korean
주주총회소집결의
AGM Information
2022-02-17 Korean